Helen I. Torley

HALOZYME THERAPEUTICS

President and Chief Executive Officer

Overview

Helen I. Torley received an average compensation of $6,261,895 at HALOZYME THERAPEUTICS from 2014 to 2017.

Annual data

2017

Non-Equity Incentive Plan$699,115
Option Awards$1,900,003
Salary$671,000
Stock Awards$1,900,011
Other$10,422
Total$5,180,551

In 2017, Helen I. Torley earned a total compensation of $5,180,551 as President and Chief Executive Officer at HALOZYME THERAPEUTICS INC.

Torley received $1,900,011 in stock awards, which accounts for 36.68% of total compensation.

Torley also received $699,115 in non-equity incentive plan, $1,900,003 in option awards, $671,000 in salary and $10,422 in other compensation.